🚚 Free delivery in France from €49 of purchase 🌍 Shipping across the European Union

Teoxane Teosyal Rha 1 2 Syringes Prefilled With 1ml

  • bvseo_sdk, p_sdk, 3.2.1
  • CLOUD, getAggregateRating, 7.62ms
  • REVIEWS, PRODUCT
  • bvseo-msg: HTTP status code of 404 was returned;
€178.00
From €79.00
Teoxane Teosyal Rha 1 2 Syringes Prefilled With 1ml
Teoxane Teosyal Rha 1 2 Syringes Prefilled With 1ml
Description Our selection Customer reviews

TEOSYAL
RHA 1
Hyaluronic Acid 15mg + lidocaine
Regular filling of fine lines, superficial wrinkles, fine wrinkles and skin breaks
Medical device
2 pre-filled syringes of TEOSYAL® RHA 1, 2 sterile needles 30G1/2" and two traceability labels

TEOSYAL® RHA 1 is a viscoelastic hyaluronic acid gel in cross-linked and non-cross-linked forms, of non-animal origin. This gel is sterile, non-pyrogenic, transparent and contains 0.3% by weight of lidocaine hydrochloride for its anaesthetic properties. Each box contains two pre-filled syringes of TEOSYAL® RHA 1. For each syringe, the box contains two sterile 30G1/2" needles and two traceability labels (one to be given to the patient and one to be kept by the doctor in the patient file). The Volumea of each syringe is indicated on the box and on each syringe.

The therapeutic indications for TEOSYAL® products are as follows:
Reconstructive surgery, filling of scar depressions, reconstruction of volumes lost through lipoatrophy in patients undergoing anti-HIV treatment.
The aesthetic indications for TEOSYAL® products are as follows:
Modification of the structure of mature skin: restoration of volumes, filling of wrinkles and skin folds, restoration of skin hydration. The TEOSYAL® RHA 1 implant is indicated for the regular filling of fine lines, superficial wrinkles, fine wrinkles and skin breaks, and for the correction of withered areas or areas marked by signs of ageing on the Face, neck and décolleté. It is also indicated for filling wrinkles and folds in the Skin (including linear and circular dark circles). Lidocaine is a local anaesthetic designed to reduce the sensation of pain.

TEOSYAL® RHA 1 is a biodegradable implant that gradually resorbs over time. Thanks to its specific viscoelastic properties, TEOSYAL® RHA 1 creates a volume that adapts regularly and uniformly to the skin's natural relief to correct the loss of density in areas withered or marked by signs of ageing, and fill in wrinkles. The non-cross-linked Hyaluronic Acid contained in TEOSYAL® RHA 1 diffuses into the cutaneous tissue as the implant is resorbed. This helps to maintain optimal hydration in the dermis and long-term reinforcement of the skin's elasticity. Depending on the corrections and results to be achieved, one or more treatment sessions may be necessary to obtain optimum results, at the discretion of the Professional in charge of the treatment.

Please note that injecting Teosyal PureSense requires a medical procedure that can only be carried out by a doctor (a doctor specialising in dermo aesthetics, a dermatologist or a plastic surgeon).

THE PRODUCTS SOLD ON OUR SITE ARE PARAPHARMACEUTICAL PRODUCTS, SO THEY CAN BE PURCHASED OVER THE COUNTER AND DO NOT REQUIRE A PRESCRIPTION.

This is a medical device.

This product cannot be returned or exchanged.

The composition may be subject to variations, so we advise you to always check the list on the purchased product.

COMPOSITION :

Hyaluronic Acid .............................................................15 mg
Lidocaine hydrochloride ...................................................3 mg
Phosphate buffer pH 7.3 .........................................qsp 1 mL


Contraindications

TEOSYAL® RHA 1 must not be used:
- For injections other than intradermal injections,
- In association with peeling, laser or ultrasound treatment,
- If the patient suffers from skin disease, inflammation or infection in or near the area to be treated,
- In the case of patients with a known hypersensitivity to Hyaluronic Acid, with a history of severe allergies or anaphylactic shock,
- In the case of known hypersensitivity to lidocaine and/or amide-type local anaesthetics,
- in patients suffering from autoimmune diseases,
- in patients suffering from heart disease and/or undergoing treatment for heart disease (beta-blockers),
- in patients with hepatocellular insufficiency and/or undergoing treatment for liver disease
- for people with epilepsy or porphyria,
- as interactions with other filling implants have not been studied, it is not recommended to inject TEOSYAL® RHA 1 in the presence of other filling implants, in the perimeter or on the area to be injected,
- in pregnant or Milk feeding women, or in Children,
- in patients with dark circles with bags (existence of a fat hernia).
Do not inject into blood vessels.
Do not inject into the eyelids.
Sportsmen and women should be warned that this product contains an active compound which may produce a positive reaction in anti-doping tests.

Side effects
The practitioner must inform the patient that there are potential side effects associated with the implantation of this device, which may occur immediately after injection or may be delayed. These include (but are not limited to)
- Local manifestations: inflammatory reactions (erythema, oedema, pain at the injection site), haematomas, itching, temporary loss of sensitivity around the injected area, dyschromia, abscesses, indurations, nodules (which may be granulomas).
- General manifestations: immediate hypersensitivity up to and including anaphylactic shock, migration of the implant.
Rare but serious adverse reactions associated with intravascular injection of fillers in the Face have been reported and include visual disturbances, even temporary or permanent blindness, skin necrosis and stroke.
The patient must also inform the practitioner of any side-effects other than those described above, or of any side-effects persisting beyond one week.
The practitioner will in turn inform the retailer of the product as soon as possible.

Precautions for use
The practitioner must take into account the presence of lidocaine in this filling product. Check the expiry date and the integrity of the packaging before use. Do not use if the expiry date has passed or if the packaging is damaged. Patients should be advised not to take high doses of vitamin E, aspirin, anti-inflammatory drugs or anticoagulants during the week prior to the injection session. Patients should be advised not to wear make-up for twelve hours after the injection and not to expose themselves to extreme temperatures (intense cold, sauna, etc.) for a week after the treatment. At the end of the treatment session, it is essential to dispose of any unused product. This device is for single use only. If it is re-used, sterility is no longer guaranteed, the gel may have deteriorated, reducing its efficiency, and the gel may have dried, making it difficult to extrude through a needle. Dispose of used needles in appropriate containers.
Storage conditions
Store between 2°C and 25°C, away from direct sunlight

The list of ingredients may be subject to variations. We advise you to always check the list on the product purchased.

The injection of TEOSYAL® RHA 1 is reserved for professionals trained in the techniques of injecting products designed to fill wrinkles. Before starting the treatment, the patient should be carefully questioned about his or her medical history, and informed about the foreseeable results of the treatment and any potential side-effects. Thoroughly disinfect the areas to be corrected. It is recommended to inject using the needles supplied in the box. The choice of injection method is at the discretion of the Professional in charge of the treatment. TEOSYAL® RHA 1 is injected into the middle dermis, in the areas of withered skin and/or skin depression that you wish to correct. If the injection is too deep, i.e. into the deep dermis or subcutaneous tissue, the correction will not have the desired effect. The volume to be injected depends on the corrections to be made. However, it is recommended not to exceed 3ml per session. It is important not to overcorrect. Massage the treated areas well to ensure that the product is evenly distributed in the corrected areas. Rigorous asepsis is essential in the dark circles area, particularly for injections under the musculo-fatty pack, in contact with the periosteum. If a cannula is used, it should be disinfected regularly during the procedure to avoid iatrogenic infection. There are several possible techniques for injecting dark circles, but two are recommended:
- Either injection with a needle, in supraperiosteal papules, slightly above the line of the dark circles, then spreading and short massage with POST PROCEDURE cream in order to place the product correctly.
- Or injection with a retro tracer cannula: The cannula is inserted deep into the skin, under the musculo-fatty pack, the product is deposited in contact with the bone and a short massage is given with POST PROCEDURE cream.
It is particularly important for the dark circles area to make a slight under-correction during the injection because of the subsequent Hydration of the product. It is recommended that the patient performs a gentle Daily use massage on the area with POST PROCEDURE cream for at least 72 hours in order to limit the formation of a lymphatic pocket.

Assembling the needle on the syringe
For optimum handling of TEOSYAL® RHA products, it is important that the needle is fitted to the syringe in accordance with the 4 steps shown in diagrams 1 to 5. If you feel any obstruction or pressure during injection, stop the injection and change needle.

To view the instructions, click on this link

  • bvseo_sdk, p_sdk, 3.2.1
  • CLOUD, getReviews, 7.09ms
  • REVIEWS, PRODUCT
  • bvseo-msg: HTTP status code of 404 was returned; HTTP status code of 404 was returned;
  • bvseo_sdk, p_sdk, 3.2.1
  • CLOUD, getContent, 7.72ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: HTTP status code of 404 was returned;
THE #EASYPARA NEWSLETTER
Join our 100% beauty and well-being community to enjoy our latest news and exclusive offers, specially designed for you. We are there to be by your side!
First Name
Email
My items (0)